If you are having trouble viewing this email, view online version .

ESE Daily News Alert - 14 May 2021

New device provides recommended doses of insulin

The Food and Drug Administration has approved a new insulin pen device which takes glucose readings and provides personal recommended insulin doses for patients with diabetes.


Semaglutide may help people with obesity lose weight

According to a study presented at the European Congress on Obesity, semaglutide may be an effective drug for treating obesity and promoting weight loss across all age groups.

Medical Xpress

Transgender hormone therapy no longer available to Swedish kids

Transgender treatment centres in Sweden, including the Karolinska Institute, will no longer prescribe hormone therapy to adolescents under the age of 16 with gender dysphoria.


Testosterone may play important role in development of endometriosis

According to research published in Evolution, Medicine and Public Health, and Evolutionary Applications, low levels of testosterone whilst in the mother’s womb may be linked to the development of endometriosis.

News Medical

The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected

To unsubscribe, please change your endocrinology news email preferences in the Member Area.